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Paroxysmal kinesigenic dyskinesia (PKD) (MIM# 128200) is a movement disorder characterized by brief episodes of involuntary movements consisting of dystonia, chorea, or myoclonus, usually triggered by sudden voluntary movements.1 Pathogenic variants in PRRT2
(MIM# 614386), located on chromosome 16p11.2, have been identiﬁed as the most common
cause of PKD.2 Most of the reported patients (approximately 80%) had the frameshift pathogenic variant c.649dupC (p. Arg217Profs*8), which causes a premature stop codon. Other
reported variants are nonsense, frameshift, or rarely missense that are predicted to cause a
truncated protein, absence of protein product through nonsense-mediated mRNA decay, or
nonfunctional protein.3 Isolated PKD is typically associated with heterozygous intragenic
variants in PRRT2. Symptomatic PKD has been reported in 6 patients with 16p11.2 microdeletion syndrome (MIM# 611913).4 PKD is thus postulated to result from PRRT2 haploinsuﬃciency. The reciprocal chromosome 16p11.2 duplication syndrome (MIM# 614671) is
associated with autism, ADHD, developmental delay, intellectual disability, epilepsy, hypotonia, congenital anomalies, and microcephaly5,6 but has not until now been associated with PKD.

MORE ONLINE

Video

Case
Identical twin brothers presented to our clinic at age 5 years for the evaluation of episodic
involuntary movements. They were born at 33 weeks’ gestation by Cesarean section because of
premature labor and breech presentation. Family history was signiﬁcant for learning disability in
both parents and mental health problems in the father. The pregnancy was complicated by
prenatal diagnosis of talipes equinovarus deformity, which prompted amniocentesis and prenatal chromosomal microarray (CMA) that revealed a 674 kilobase interstitial microduplication at 16p11.2 (29,517,699–30,191,895) x3 (hg19).
Developmental delay became apparent at age 18 months, when they were unable to sit independently or speak single words. Both twins had impaired social interaction and impulsive
behavior and were diagnosed with autistic spectrum disorder and started applied behavior analysis.
Their foot anomaly was complicated by tendo-Achilles contractures and treated with serial casting
and bilateral heel cord tenotomies. They subsequently walked independently at age 26 months.
Shortly after age 2 years, 1 twin developed 30- to 40-second episodes of dystonic posturing and
athetosis of the upper and lower limbs (Video 1, links.lww.com/NXG/A358), triggered by
sudden voluntary movements. At age 4 years, he developed generalized tonic-clonic seizures
(GTCS), for which he started oxcarbazepine (OXC). At age 5 years, the episodes of involuntary
movements occurred multiple times per day. Trihexyphenidyl partially controlled the
symptoms.
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Figure Duplication Map of 16p11.2

Schematic representation of the duplicated 16p11.2 region using the University of California Santa Cruz Genome Browser (genome.ucsc.edu/). Top: a red
rectangle indicates the duplicated region on the chromosome ideogram of 16p11.2. Bottom: a detailed map of the duplicated region, flanked by 2 blue lines,
illustrates affected genomic coordinates and locations of Online Mendelian Inheritance in Man genes. Dark green boxes indicate disease-causing genes (e.g.,
PRRT2) for which the molecular basis of the disorder is known.

Investigations including brain and whole-spine MRI, urine
organic acids, serum amino acids, and copper and ceruloplasmin levels were unremarkable. On our initial examination,
he had mild generalized hypotonia without hyperreﬂexia or
dysmorphic features. He was diagnosed with PKD. OXC was
increased and trihexyphenidyl was discontinued. Ultimately,
both the seizures and PKD episodes were controlled with
OXC 32 mg/kg/d. Of note, a higher dose was needed to
control the episodes of PKD than to control his seizures.
The other twin brother experienced GTCS at age 3 years,
which subsided without any treatment, and experienced
milder episodes of PKD that were controlled completely with
OXC 13 mg/kg/d.
At age 8 years, both developed persistent urinary retention,
and lumber spine MRI revealed a tethered cord, which was
surgically released with subsequent improvement in bladder
and bowel function. Postnatal CMA revealed a 660 kilobase
microduplication at 16p11.2 (29,517,698–30,177,240) x3
(hg19) (ﬁgure), which was almost identical to the result of the
prenatal CMA. Targeted sequencing of PRRT2 did not
identify pathogenic variants.

Discussion
We report monozygotic twins with chromosome 16p11.2
microduplication manifesting symptomatic PKD. Although
16p11.2 microduplication and deletion have many common
clinical features,5 cases of 16p11.2 microduplication have not
been reported in association with PKD. Some of the twins’
symptoms such as developmental delay, autistic spectrum
disorder, hypotonia, and epilepsy commonly occur in
16p11.2 duplication carriers, but other clinical features of the
syndrome such as skin lesions (e.g., café-au-lait spots and
sacral dimples), cranial nerve abnormalities, hyper or
hyporeﬂexia, tremor, tics, abnormal agility, abnormal brain
MRI ﬁndings, or microcephaly were not observed in our
patients.5
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The PRRT2-related phenotypes such as PKD are caused by
loss of function in 16p11.2 deletion and PPRT2 sequence
variants.4 A mouse model of PRRT2 deﬁciency demonstrated
that loss of function in PRRT2 deletion can be associated with
abnormal synaptic transmission by altering soluble
N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein function and behavioral episodes
resembling PKD.7
The occurrence of PKD in our patients with 16p11.2 microduplication syndrome suggests that PRRT2 haploinsuﬃciency
is not the only possible mechanism underlying PKD, as has
been previously hypothesized. Although we cannot exclude
the possibility that a hypomorphic allele in the regulatory
region of PRRT2 exists as a second hit, our case suggests that
dosage of PRRT2 is important and that 16p11.2 microduplication, presumably associated with PRRT2 gain of
function may also cause PKD. The remarkably reduced penetrance for PKD in 16p11.2 rearrangements may relate to
common polymorphisms on the remaining hemizygous allele,
diﬀerent genotypes elsewhere in the genome, or sexdependent penetrance because all patients reported so far
with PKD and these 16p11.2 alterations were men. Although
PRRT2 haploinsuﬃciency can be the mechanism for dosage
sensitivity in 16p11.2 deletion, the pathogenicity in the reciprocal microduplication is not clear, but the surplus of
PRRT2 may interfere with the dosage balance required for the
SNARE protein.
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